Global Oral Cholera Vaccine Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Publisher Name :
Date: 20-Sep-2022
No. of pages: 80
Inquire Before Buying

Report Scope

This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers' production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Oral Cholera Vaccine manufacturers, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.

This report also includes a discussion of the major players across each regional Oral Cholera Vaccine market. Further, it explains the major drivers and regional dynamics of the global Oral Cholera Vaccine market and current trends within the industry.

Key Companies Covered

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

- PaxVax

- Sanofi

- Valneva

- EuBiologics

Market Segments

This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.

Oral Cholera Vaccine Segment by Type

- Shanchol

- Dukoral

- Vaxchora

- Others

Oral Cholera Vaccine Segment by Application

- Hospital

- Research & Academic Laboratories

- Pharmaceutical & Biotechnology Companies

- Others

Key Regions & Countries

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - China Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Oral Cholera Vaccine market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Report Includes:

This report presents an overview of global market for Oral Cholera Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.

This report researches the key producers of Oral Cholera Vaccine, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Oral Cholera Vaccine, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Oral Cholera Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Oral Cholera Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Oral Cholera Vaccine sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including PaxVax, Sanofi, Valneva and EuBiologics, etc.

Global Oral Cholera Vaccine Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Oral Cholera Vaccine Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Shanchol
1.2.3 Dukoral
1.2.4 Vaxchora
1.2.5 Others
1.3 Market Segment by Application
1.3.1 Global Oral Cholera Vaccine Market Share by Application (2017 VS 2021 VS 2028)
1.3.2 Hospital
1.3.3 Research & Academic Laboratories
1.3.4 Pharmaceutical & Biotechnology Companies
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Oral Cholera Vaccine Market Size (2017-2028)
2.1.1 Global Oral Cholera Vaccine Revenue (2017-2028)
2.1.2 Global Oral Cholera Vaccine Sales (2017-2028)
2.2 Global Oral Cholera Vaccine Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.2.1 Global Oral Cholera Vaccine Sales by Regions (2017-2022)
2.2.2 Global Oral Cholera Vaccine Revenue by Regions (2017-2022)
2.3 Global Oral Cholera Vaccine Market Size Forecast by Region
2.3.1 Global Oral Cholera Vaccine Sales Forecast by Region (2023-2028)
2.3.2 Global Oral Cholera Vaccine Revenue Forecast by Region (2023-2028)
2.4 Global Top Oral Cholera Vaccine Regions (Countries) Ranking by Market Size
2.5 Oral Cholera Vaccine Market Dynamics
2.5.1 Oral Cholera Vaccine Market Trends
2.5.2 Oral Cholera Vaccine Market Drivers
2.5.3 Oral Cholera Vaccine Market Challenges
2.5.4 Oral Cholera Vaccine Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Oral Cholera Vaccine Manufacturers by Sales (2017-2022)
3.1.1 Global Oral Cholera Vaccine Sales by Manufacturers (2017-2022)
3.1.2 Global Oral Cholera Vaccine Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global 5 and 10 Largest Manufacturers by Oral Cholera Vaccine Sales in 2021
3.2 Global Top Manufacturers Oral Cholera Vaccine by Revenue
3.2.1 Global Oral Cholera Vaccine Revenue by Manufacturers (2017-2022)
3.2.2 Top Oral Cholera Vaccine Manufacturers Covered: Ranking by Revenue
3.2.3 Global Oral Cholera Vaccine Revenue Share by Manufacturers (2017-2022)
3.2.4 Global Oral Cholera Vaccine Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Oral Cholera Vaccine as of 2021)
3.4 Global Oral Cholera Vaccine Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Oral Cholera Vaccine Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Oral Cholera Vaccine Market
3.7 Key Manufacturers Oral Cholera Vaccine Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Oral Cholera Vaccine Market Size by Type
4.1 Global Oral Cholera Vaccine Historic Market Review by Type (2017-2022)
4.1.1 Global Oral Cholera Vaccine Sales Market Share by Type (2017-2022)
4.1.2 Global Oral Cholera Vaccine Revenue Market Share by Type (2017-2022)
4.1.3 Oral Cholera Vaccine Price by Type (2017-2022)
4.2 Global Oral Cholera Vaccine Market Estimates and Forecasts by Type (2023-2028)
4.2.1 Global Oral Cholera Vaccine Sales Forecast by Type (2023-2028)
4.2.2 Global Oral Cholera Vaccine Revenue Forecast by Type (2023-2028)
4.2.3 Oral Cholera Vaccine Price Forecast by Type (2023-2028)
5 Global Oral Cholera Vaccine Market Size by Application
5.1 Global Oral Cholera Vaccine Historic Market Review by Application (2017-2022)
5.1.1 Global Oral Cholera Vaccine Sales Market Share by Application (2017-2022)
5.1.2 Global Oral Cholera Vaccine Revenue Market Share by Application (2017-2022)
5.1.3 Oral Cholera Vaccine Price by Application (2017-2022)
5.2 Global Oral Cholera Vaccine Market Estimates and Forecasts by Application (2023-2028)
5.2.1 Global Oral Cholera Vaccine Sales Forecast by Application (2023-2028)
5.2.2 Global Oral Cholera Vaccine Revenue Forecast by Application (2023-2028)
5.2.3 Oral Cholera Vaccine Price Forecast by Application (2023-2028)
6 North America
6.1 North America Oral Cholera Vaccine Sales Breakdown by Company
6.1.1 North America Oral Cholera Vaccine Sales by Company (2017-2022)
6.1.2 North America Oral Cholera Vaccine Revenue by Company (2017-2022)
6.2 North America Oral Cholera Vaccine Market Size by Type
6.2.1 North America Oral Cholera Vaccine Sales by Type (2017-2028)
6.2.2 North America Oral Cholera Vaccine Revenue by Type (2017-2028)
6.3 North America Oral Cholera Vaccine Market Size by Application
6.3.1 North America Oral Cholera Vaccine Sales by Application (2017-2028)
6.3.2 North America Oral Cholera Vaccine Revenue by Application (2017-2028)
6.4 North America Oral Cholera Vaccine Market Size by Country
6.4.1 North America Oral Cholera Vaccine Sales by Country (2017-2028)
6.4.2 North America Oral Cholera Vaccine Revenue by Country (2017-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Oral Cholera Vaccine Sales Breakdown by Company
7.1.1 Europe Oral Cholera Vaccine Sales by Company (2017-2022)
7.1.2 Europe Oral Cholera Vaccine Revenue by Company (2017-2022)
7.2 Europe Oral Cholera Vaccine Market Size by Type
7.2.1 Europe Oral Cholera Vaccine Sales by Type (2017-2028)
7.2.2 Europe Oral Cholera Vaccine Revenue by Type (2017-2028)
7.3 Europe Oral Cholera Vaccine Market Size by Application
7.3.1 Europe Oral Cholera Vaccine Sales by Application (2017-2028)
7.3.2 Europe Oral Cholera Vaccine Revenue by Application (2017-2028)
7.4 Europe Oral Cholera Vaccine Market Size by Country
7.4.1 Europe Oral Cholera Vaccine Sales by Country (2017-2028)
7.4.2 Europe Oral Cholera Vaccine Revenue by Country (2017-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Oral Cholera Vaccine Sales Breakdown by Company
8.1.1 Asia Pacific Oral Cholera Vaccine Sales by Company (2017-2022)
8.1.2 Asia Pacific Oral Cholera Vaccine Revenue by Company (2017-2022)
8.2 Asia Pacific Oral Cholera Vaccine Market Size by Type
8.2.1 Asia Pacific Oral Cholera Vaccine Sales by Type (2017-2028)
8.2.2 Asia Pacific Oral Cholera Vaccine Revenue by Type (2017-2028)
8.3 Asia Pacific Oral Cholera Vaccine Market Size by Application
8.3.1 Asia Pacific Oral Cholera Vaccine Sales by Application (2017-2028)
8.3.2 Asia Pacific Oral Cholera Vaccine Revenue by Application (2017-2028)
8.4 Asia Pacific Oral Cholera Vaccine Market Size by Region
8.4.1 Asia Pacific Oral Cholera Vaccine Sales by Region
8.4.2 Asia Pacific Oral Cholera Vaccine Revenue by Region
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 China Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
9 Latin America
9.1 Latin America Oral Cholera Vaccine Sales Breakdown by Company
9.1.1 Latin America Oral Cholera Vaccine Sales by Company (2017-2022)
9.1.2 Latin America Oral Cholera Vaccine Revenue by Company (2017-2022)
9.2 Latin America Oral Cholera Vaccine Market Size by Type
9.2.1 Latin America Oral Cholera Vaccine Sales by Type (2017-2028)
9.2.2 Latin America Oral Cholera Vaccine Revenue by Type (2017-2028)
9.3 Latin America Oral Cholera Vaccine Market Size by Application
9.3.1 Latin America Oral Cholera Vaccine Sales by Application (2017-2028)
9.3.2 Latin America Oral Cholera Vaccine Revenue by Application (2017-2028)
9.4 Latin America Oral Cholera Vaccine Market Size by Country
9.4.1 Latin America Oral Cholera Vaccine Sales by Country (2017-2028)
9.4.2 Latin America Oral Cholera Vaccine Revenue by Country (2017-2028)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Oral Cholera Vaccine Sales Breakdown by Company
10.1.1 Middle East and Africa Oral Cholera Vaccine Sales by Company (2017-2022)
10.1.2 Middle East and Africa Oral Cholera Vaccine Revenue by Company (2017-2022)
10.2 Middle East and Africa Oral Cholera Vaccine Market Size by Type
10.2.1 Middle East and Africa Oral Cholera Vaccine Sales by Type (2017-2028)
10.2.2 Middle East and Africa Oral Cholera Vaccine Revenue by Type (2017-2028)
10.3 Middle East and Africa Oral Cholera Vaccine Market Size by Application
10.3.1 Middle East and Africa Oral Cholera Vaccine Sales by Application (2017-2028)
10.3.2 Middle East and Africa Oral Cholera Vaccine Revenue by Application (2017-2028)
10.4 Middle East and Africa Oral Cholera Vaccine Market Size by Country
10.4.1 Middle East and Africa Oral Cholera Vaccine Sales by Country (2017-2028)
10.4.2 Middle East and Africa Oral Cholera Vaccine Revenue by Country (2017-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Company Profiles
11.1 PaxVax
11.1.1 PaxVax Corporation Information
11.1.2 PaxVax Overview
11.1.3 PaxVax Oral Cholera Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.1.4 PaxVax Oral Cholera Vaccine Products and Services
11.1.5 PaxVax Oral Cholera Vaccine SWOT Analysis
11.1.6 PaxVax Recent Developments
11.2 Sanofi
11.2.1 Sanofi Corporation Information
11.2.2 Sanofi Overview
11.2.3 Sanofi Oral Cholera Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.2.4 Sanofi Oral Cholera Vaccine Products and Services
11.2.5 Sanofi Oral Cholera Vaccine SWOT Analysis
11.2.6 Sanofi Recent Developments
11.3 Valneva
11.3.1 Valneva Corporation Information
11.3.2 Valneva Overview
11.3.3 Valneva Oral Cholera Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.3.4 Valneva Oral Cholera Vaccine Products and Services
11.3.5 Valneva Oral Cholera Vaccine SWOT Analysis
11.3.6 Valneva Recent Developments
11.4 EuBiologics
11.4.1 EuBiologics Corporation Information
11.4.2 EuBiologics Overview
11.4.3 EuBiologics Oral Cholera Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.4.4 EuBiologics Oral Cholera Vaccine Products and Services
11.4.5 EuBiologics Oral Cholera Vaccine SWOT Analysis
11.4.6 EuBiologics Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Oral Cholera Vaccine Value Chain Analysis
12.2 Oral Cholera Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Oral Cholera Vaccine Production Mode & Process
12.4 Oral Cholera Vaccine Sales and Marketing
12.4.1 Oral Cholera Vaccine Sales Channels
12.4.2 Oral Cholera Vaccine Distributors
12.5 Oral Cholera Vaccine Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Oral Cholera Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Shanchol
Table 3. Major Manufacturers of Dukoral
Table 4. Major Manufacturers of Vaxchora
Table 5. Major Manufacturers of Others
Table 6. Global Oral Cholera Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Oral Cholera Vaccine Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 8. Global Oral Cholera Vaccine Sales by Region (2017-2022) & (K Units)
Table 9. Global Oral Cholera Vaccine Sales Market Share by Region (2017-2022)
Table 10. Global Oral Cholera Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Oral Cholera Vaccine Revenue Market Share by Region (2017-2022)
Table 12. Global Oral Cholera Vaccine Sales Forecast by Region (2023-2028) & (K Units)
Table 13. Global Oral Cholera Vaccine Sales Market Share Forecast by Region (2023-2028)
Table 14. Global Oral Cholera Vaccine Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 15. Global Oral Cholera Vaccine Revenue Market Share Forecast by Region (2023-2028)
Table 16. Top Oral Cholera Vaccine Regions (Countries) Ranking by Market Size (US$ Million) in 2021
Table 17. Oral Cholera Vaccine Market Trends
Table 18. Oral Cholera Vaccine Market Drivers
Table 19. Oral Cholera Vaccine Market Challenges
Table 20. Oral Cholera Vaccine Market Restraints
Table 21. Global Oral Cholera Vaccine Sales by Manufacturers (2017-2022) & (K Units)
Table 22. Global Oral Cholera Vaccine Sales Share by Manufacturers (2017-2022)
Table 23. Global Oral Cholera Vaccine Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 24. Ranking of Global Top Oral Cholera Vaccine Manufacturers by Revenue (US$ Million) in 2021
Table 25. Oral Cholera Vaccine Revenue Share by Manufacturers (2017-2022)
Table 26. Global Oral Cholera Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 27. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Oral Cholera Vaccine as of 2021)
Table 28. Key Manufacturers Oral Cholera Vaccine Average Selling Price (ASP) & (2017-2022) & (USD/Unit)
Table 29. Key Manufacturers Oral Cholera Vaccine Plants/Factories Distribution
Table 30. Key Manufacturers Oral Cholera Vaccine Area Served
Table 31. Date of Key Manufacturers Enter into Oral Cholera Vaccine Market
Table 32. Key Manufacturers Oral Cholera Vaccine Product Type
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Oral Cholera Vaccine Sales (K Units) by Type (2017-2022)
Table 35. Global Oral Cholera Vaccine Sales Share by Type (2017-2022)
Table 36. Global Oral Cholera Vaccine Revenue (US$ Million) Market Share by Type (2017-2022)
Table 37. Global Oral Cholera Vaccine Price (K Units) by Type (2017-2022)
Table 38. Global Oral Cholera Vaccine Sales (K Units) by Type (2023-2028)
Table 39. Global Oral Cholera Vaccine Sales Share by Type (2023-2028)
Table 40. Global Oral Cholera Vaccine Revenue (US$ Million) Market Share by Type (2023-2028)
Table 41. Global Oral Cholera Vaccine Revenue Share by Type (2023-2028)
Table 42. Global Oral Cholera Vaccine Price (K Units) by Type (2023-2028)
Table 43. Global Oral Cholera Vaccine Sales (K Units) by Application (2017-2022)
Table 44. Global Oral Cholera Vaccine Sales Share by Application (2017-2022)
Table 45. Global Oral Cholera Vaccine Revenue (US$ Million) Market Share by Application (2017-2022)
Table 46. Global Oral Cholera Vaccine Price (K Units) by Application (2017-2022)
Table 47. Global Oral Cholera Vaccine Sales (K Units) by Application (2023-2028)
Table 48. Global Oral Cholera Vaccine Sales Share by Application (2023-2028)
Table 49. Global Oral Cholera Vaccine Revenue (US$ Million) Market Share by Application (2023-2028)
Table 50. Global Oral Cholera Vaccine Revenue Share by Application (2023-2028)
Table 51. Global Oral Cholera Vaccine Price (K Units) by Application (2023-2028)
Table 52. North America Oral Cholera Vaccine Sales by Company (2017-2022) & (K Units)
Table 53. North America Oral Cholera Vaccine Sales Market Share by Company (2017-2022)
Table 54. North America Oral Cholera Vaccine Revenue by Company (2017-2022) & (US$ Million)
Table 55. North America Oral Cholera Vaccine Revenue Market Share by Company (2017-2022)
Table 56. North America Oral Cholera Vaccine Sales by Type (2017-2022) & (K Units)
Table 57. North America Oral Cholera Vaccine Sales by Type (2023-2028) & (K Units)
Table 58. North America Oral Cholera Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 59. North America Oral Cholera Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 60. North America Oral Cholera Vaccine Sales by Application (2017-2022) & (K Units)
Table 61. North America Oral Cholera Vaccine Sales by Application (2023-2028) & (K Units)
Table 62. North America Oral Cholera Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 63. North America Oral Cholera Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 64. North America Oral Cholera Vaccine Sales by Country (2017-2022) & (K Units)
Table 65. North America Oral Cholera Vaccine Sales by Country (2023-2028) & (K Units)
Table 66. North America Oral Cholera Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 67. North America Oral Cholera Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 68. Europe Oral Cholera Vaccine Sales by Company (2017-2022) & (K Units)
Table 69. Europe Oral Cholera Vaccine Sales Market Share by Company (2017-2022)
Table 70. Europe Oral Cholera Vaccine Revenue by Company (2017-2022) & (US$ Million)
Table 71. Europe Oral Cholera Vaccine Revenue Market Share by Company (2017-2022)
Table 72. Europe Oral Cholera Vaccine Sales by Type (2017-2022) & (K Units)
Table 73. Europe Oral Cholera Vaccine Sales by Type (2023-2028) & (K Units)
Table 74. Europe Oral Cholera Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 75. Europe Oral Cholera Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 76. Europe Oral Cholera Vaccine Sales by Application (2017-2022) & (K Units)
Table 77. Europe Oral Cholera Vaccine Sales by Application (2023-2028) & (K Units)
Table 78. Europe Oral Cholera Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 79. Europe Oral Cholera Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 80. Europe Oral Cholera Vaccine Sales by Country (2017-2022) & (K Units)
Table 81. Europe Oral Cholera Vaccine Sales by Country (2023-2028) & (K Units)
Table 82. Europe Oral Cholera Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 83. Europe Oral Cholera Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 84. Asia Pacific Oral Cholera Vaccine Sales by Company (2017-2022) & (K Units)
Table 85. Asia Pacific Oral Cholera Vaccine Sales Market Share by Company (2017-2022)
Table 86. Asia Pacific Oral Cholera Vaccine Revenue by Company (2017-2022) & (US$ Million)
Table 87. Asia Pacific Oral Cholera Vaccine Revenue Market Share by Company (2017-2022)
Table 88. Asia Pacific Oral Cholera Vaccine Sales by Type (2017-2022) & (K Units)
Table 89. Asia Pacific Oral Cholera Vaccine Sales by Type (2023-2028) & (K Units)
Table 90. Asia Pacific Oral Cholera Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 91. Asia Pacific Oral Cholera Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 92. Asia Pacific Oral Cholera Vaccine Sales by Application (2017-2022) & (K Units)
Table 93. Asia Pacific Oral Cholera Vaccine Sales by Application (2023-2028) & (K Units)
Table 94. Asia Pacific Oral Cholera Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 95. Asia Pacific Oral Cholera Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 96. Asia Pacific Oral Cholera Vaccine Sales by Region (2017-2022) & (K Units)
Table 97. Asia Pacific Oral Cholera Vaccine Sales by Region (2023-2028) & (K Units)
Table 98. Asia Pacific Oral Cholera Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 99. Asia Pacific Oral Cholera Vaccine Revenue by Region (2023-2028) & (US$ Million)
Table 100. Latin America Oral Cholera Vaccine Sales by Company (2017-2022) & (K Units)
Table 101. Latin America Oral Cholera Vaccine Sales Market Share by Company (2017-2022)
Table 102. Latin America Oral Cholera Vaccine Revenue by Company (2017-2022) & (US$ Million)
Table 103. Latin America Oral Cholera Vaccine Revenue Market Share by Company (2017-2022)
Table 104. Latin America Oral Cholera Vaccine Sales by Type (2017-2022) & (K Units)
Table 105. Latin America Oral Cholera Vaccine Sales by Type (2023-2028) & (K Units)
Table 106. Latin America Oral Cholera Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 107. Latin America Oral Cholera Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 108. Latin America Oral Cholera Vaccine Sales by Application (2017-2022) & (K Units)
Table 109. Latin America Oral Cholera Vaccine Sales by Application (2023-2028) & (K Units)
Table 110. Latin America Oral Cholera Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 111. Latin America Oral Cholera Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 112. Latin America Oral Cholera Vaccine Sales by Country (2017-2022) & (K Units)
Table 113. Latin America Oral Cholera Vaccine Sales by Country (2023-2028) & (K Units)
Table 114. Latin America Oral Cholera Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 115. Latin America Oral Cholera Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 116. Middle East and Africa Oral Cholera Vaccine Sales by Company (2017-2022) & (K Units)
Table 117. Middle East and Africa Oral Cholera Vaccine Sales Market Share by Company (2017-2022)
Table 118. Middle East and Africa Oral Cholera Vaccine Revenue by Company (2017-2022) & (US$ Million)
Table 119. Middle East and Africa Oral Cholera Vaccine Revenue Market Share by Company (2017-2022)
Table 120. Middle East and Africa Oral Cholera Vaccine Sales by Type (2017-2022) & (K Units)
Table 121. Middle East and Africa Oral Cholera Vaccine Sales by Type (2023-2028) & (K Units)
Table 122. Middle East and Africa Oral Cholera Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 123. Middle East and Africa Oral Cholera Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 124. Middle East and Africa Oral Cholera Vaccine Sales by Application (2017-2022) & (K Units)
Table 125. Middle East and Africa Oral Cholera Vaccine Sales by Application (2023-2028) & (K Units)
Table 126. Middle East and Africa Oral Cholera Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 127. Middle East and Africa Oral Cholera Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 128. Middle East and Africa Oral Cholera Vaccine Sales by Country (2017-2022) & (K Units)
Table 129. Middle East and Africa Oral Cholera Vaccine Sales by Country (2023-2028) & (K Units)
Table 130. Middle East and Africa Oral Cholera Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 131. Middle East and Africa Oral Cholera Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 132. PaxVax Corporation Information
Table 133. PaxVax Description and Overview
Table 134. PaxVax Oral Cholera Vaccine Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 135. PaxVax Oral Cholera Vaccine Product and Services
Table 136. PaxVax Oral Cholera Vaccine SWOT Analysis
Table 137. PaxVax Recent Developments
Table 138. Sanofi Corporation Information
Table 139. Sanofi Description and Overview
Table 140. Sanofi Oral Cholera Vaccine Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 141. Sanofi Oral Cholera Vaccine Product and Services
Table 142. Sanofi Oral Cholera Vaccine SWOT Analysis
Table 143. Sanofi Recent Developments
Table 144. Valneva Corporation Information
Table 145. Valneva Description and Overview
Table 146. Valneva Oral Cholera Vaccine Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 147. Valneva Oral Cholera Vaccine Product and Services
Table 148. Valneva Oral Cholera Vaccine SWOT Analysis
Table 149. Valneva Recent Developments
Table 150. EuBiologics Corporation Information
Table 151. EuBiologics Description and Overview
Table 152. EuBiologics Oral Cholera Vaccine Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 153. EuBiologics Oral Cholera Vaccine Product and Services
Table 154. EuBiologics Oral Cholera Vaccine SWOT Analysis
Table 155. EuBiologics Recent Developments
Table 156. Key Raw Materials Lists
Table 157. Raw Materials Key Suppliers Lists
Table 158. Oral Cholera Vaccine Distributors List
Table 159. Oral Cholera Vaccine Customers List
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources
List of Figures
Figure 1. Oral Cholera Vaccine Product Picture
Figure 2. Global Oral Cholera Vaccine Sales Market Share by Type in 2021 & 2028
Figure 3. Shanchol Product Picture
Figure 4. Dukoral Product Picture
Figure 5. Vaxchora Product Picture
Figure 6. Others Product Picture
Figure 7. Global Oral Cholera Vaccine Sales Market Share by Application in 2021 & 2028
Figure 8. Hospital Use Case
Figure 9. Research & Academic Laboratories Use Case
Figure 10. Pharmaceutical & Biotechnology Companies Use Case
Figure 11. Others Use Case
Figure 12. Oral Cholera Vaccine Report Years Considered
Figure 13. Global Oral Cholera Vaccine Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Oral Cholera Vaccine Market Size 2017-2028 (US$ Million)
Figure 15. Global Oral Cholera Vaccine Sales (2017-2022) & (K Units)
Figure 16. Global Oral Cholera Vaccine Market Size Market Share by Region: 2021 VS 2028
Figure 17. Global Oral Cholera Vaccine Sales Market Share by Region (2017-2022)
Figure 18. Global Oral Cholera Vaccine Sales Market Share by Region in 2021
Figure 19. Global Oral Cholera Vaccine Revenue Market Share by Region in 2017 VS 2021
Figure 20. Global Oral Cholera Vaccine Sales Share by Manufacturers in 2021
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Oral Cholera Vaccine Sales in 2021
Figure 22. Oral Cholera Vaccine Revenue Share by Manufacturers in 2021
Figure 23. Oral Cholera Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 24. Global Oral Cholera Vaccine Revenue Share by Type (2017-2022)
Figure 25. Global Oral Cholera Vaccine Revenue Growth Rate by Type in 2017 & 2021
Figure 26. Global Oral Cholera Vaccine Revenue Share by Application (2017-2022)
Figure 27. Global Oral Cholera Vaccine Revenue Growth Rate by Application in 2017 & 2021
Figure 28. North America Oral Cholera Vaccine Sales Market Share by Type (2017-2028)
Figure 29. North America Oral Cholera Vaccine Revenue Market Share by Type (2017-2028)
Figure 30. North America Oral Cholera Vaccine Sales Market Share by Application (2017-2028)
Figure 31. North America Oral Cholera Vaccine Revenue Market Share by Application (2017-2028)
Figure 32. North America Oral Cholera Vaccine Sales Share by Country (2017-2028)
Figure 33. North America Oral Cholera Vaccine Revenue Share by Country (2017-2028)
Figure 34. U.S. Oral Cholera Vaccine Revenue (2017-2028) & (US$ Million)
Figure 35. Canada Oral Cholera Vaccine Revenue (2017-2028) & (US$ Million)
Figure 36. Europe Oral Cholera Vaccine Sales Market Share by Type (2017-2028)
Figure 37. Europe Oral Cholera Vaccine Revenue Market Share by Type (2017-2028)
Figure 38. Europe Oral Cholera Vaccine Sales Market Share by Application (2017-2028)
Figure 39. Europe Oral Cholera Vaccine Revenue Market Share by Application (2017-2028)
Figure 40. Europe Oral Cholera Vaccine Sales Share by Country (2017-2028)
Figure 41. Europe Oral Cholera Vaccine Revenue Share by Country (2017-2028)
Figure 42. Germany Oral Cholera Vaccine Revenue (2017-2028) & (US$ Million)
Figure 43. France Oral Cholera Vaccine Revenue (2017-2028) & (US$ Million)
Figure 44. U.K. Oral Cholera Vaccine Revenue (2017-2028) & (US$ Million)
Figure 45. Italy Oral Cholera Vaccine Revenue (2017-2028) & (US$ Million)
Figure 46. Russia Oral Cholera Vaccine Revenue (2017-2028) & (US$ Million)
Figure 47. Asia Pacific Oral Cholera Vaccine Sales Market Share by Type (2017-2028)
Figure 48. Asia Pacific Oral Cholera Vaccine Revenue Market Share by Type (2017-2028)
Figure 49. Asia Pacific Oral Cholera Vaccine Sales Market Share by Application (2017-2028)
Figure 50. Asia Pacific Oral Cholera Vaccine Revenue Market Share by Application (2017-2028)
Figure 51. Asia Pacific Oral Cholera Vaccine Sales Share by Region (2017-2028)
Figure 52. Asia Pacific Oral Cholera Vaccine Revenue Share by Region (2017-2028)
Figure 53. China Oral Cholera Vaccine Revenue (2017-2028) & (US$ Million)
Figure 54. Japan Oral Cholera Vaccine Revenue (2017-2028) & (US$ Million)
Figure 55. South Korea Oral Cholera Vaccine Revenue (2017-2028) & (US$ Million)
Figure 56. India Oral Cholera Vaccine Revenue (2017-2028) & (US$ Million)
Figure 57. Australia Oral Cholera Vaccine Revenue (2017-2028) & (US$ Million)
Figure 58. China Taiwan Oral Cholera Vaccine Revenue (2017-2028) & (US$ Million)
Figure 59. Indonesia Oral Cholera Vaccine Revenue (2017-2028) & (US$ Million)
Figure 60. Thailand Oral Cholera Vaccine Revenue (2017-2028) & (US$ Million)
Figure 61. Malaysia Oral Cholera Vaccine Revenue (2017-2028) & (US$ Million)
Figure 62. Latin America Oral Cholera Vaccine Sales Market Share by Type (2017-2028)
Figure 63. Latin America Oral Cholera Vaccine Revenue Market Share by Type (2017-2028)
Figure 64. Latin America Oral Cholera Vaccine Sales Market Share by Application (2017-2028)
Figure 65. Latin America Oral Cholera Vaccine Revenue Market Share by Application (2017-2028)
Figure 66. Latin America Oral Cholera Vaccine Sales Share by Country (2017-2028)
Figure 67. Latin America Oral Cholera Vaccine Revenue Share by Country (2017-2028)
Figure 68. Mexico Oral Cholera Vaccine Revenue (2017-2028) & (US$ Million)
Figure 69. Brazil Oral Cholera Vaccine Revenue (2017-2028) & (US$ Million)
Figure 70. Argentina Oral Cholera Vaccine Revenue (2017-2028) & (US$ Million)
Figure 71. Middle East and Africa Oral Cholera Vaccine Sales Market Share by Type (2017-2028)
Figure 72. Middle East and Africa Oral Cholera Vaccine Revenue Market Share by Type (2017-2028)
Figure 73. Middle East and Africa Oral Cholera Vaccine Sales Market Share by Application (2017-2028)
Figure 74. Middle East and Africa Oral Cholera Vaccine Revenue Market Share by Application (2017-2028)
Figure 75. Middle East and Africa Oral Cholera Vaccine Sales Share by Country (2017-2028)
Figure 76. Middle East and Africa Oral Cholera Vaccine Revenue Share by Country (2017-2028)
Figure 77. Turkey Oral Cholera Vaccine Revenue (2017-2028) & (US$ Million)
Figure 78. Saudi Arabia Oral Cholera Vaccine Revenue (2017-2028) & (US$ Million)
Figure 79. UAE Oral Cholera Vaccine Revenue (2017-2028) & (US$ Million)
Figure 80. Oral Cholera Vaccine Value Chain
Figure 81. Oral Cholera Vaccine Production Process
Figure 82. Channels of Distribution
Figure 83. Distributors Profiles
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed
  • Global Albumin (as Excipient) Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028
    Published: 29-Sep-2022        Price: US 5900 Onwards        Pages: 114
    Albumin is a water-soluble globular protein produced in the liver. It accounts for 50% of blood plasma proteins. These play a vital role in regulating blood volume and act as transporters for molecules such as few hormones, bile salts, and ions. Albumin is commonly used as blood volumizer in rare diseases, burns, shocks, liver conditions, and other blood loss trauma and surgeries. Highlights Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, t......
  • Global Bendamustine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028
    Published: 29-Sep-2022        Price: US 5900 Onwards        Pages: 106
    Bendamustine is a chemotherapy medication used in the treatment of chronic lymphocytic leukemia (CLL), multiple myeloma, and non-Hodgkin's lymphoma. It is given by injection into a vein. Highlights Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Bendamustine market is projected to reach US$ 743.1 million by 2028 from an estimated US$ 784.6 million in 2022, at a CAGR of -0.9% during 2023 and 2028. Market competition is inte......
  • Global Mitomycin Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028
    Published: 29-Sep-2022        Price: US 5900 Onwards        Pages: 104
    Mitomycin is an antibiotic which acts as a double-stranded DNA alkylating agent. It covalently crosslinks DNA, inhibiting DNA synthesis and cell proliferation It acts by way of reductive activation either through low pH or NAD(P)H:quinone oxidoreductase (DT-diaphorase) or NADH cytochrome c reductase (Mao et al.; Cummings et al.). Highlights Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Mitomycin market is projected to reach US$......
  • Global Recombinant Human Serum Albumin Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028
    Published: 29-Sep-2022        Price: US 5900 Onwards        Pages: 104
    Recombinant Human Serum Albumin (Rec. HSA) is animal origin free expressed in E.coli without animal or human derived raw materials. It is also free from other contaminating serum proteins. Recombinant human serum albumin (rHSA) is genetically engineered and derived from a rice-based expression system. It is a highly purified and completely animal-, virus-, and bacteria-free product that was developed as an alternative to plasma-derived HSA, to which it is structurally equivalent. ......
  • Global Sevoflurane (Sevoflurane Source) Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028
    Published: 29-Sep-2022        Price: US 5900 Onwards        Pages: 98
    Sevoflurane is a halogenated general inhalation anesthetic drug. Highlights Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Sevoflurane (Sevoflurane Source) market is projected to reach US$ 1276.4 million by 2028 from an estimated US$ 1315.4 million in 2022, at a CAGR of -0.5% during 2023 and 2028. The top 5 players was expected to reach at about 65% market share by 2020, in terms of the globle sevoflurane revenue. ......
  • Global Iloprost Drugs Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028
    Published: 29-Sep-2022        Price: US 5900 Onwards        Pages: 76
    Iloprost is a drug used to treat pulmonary arterial hypertension (PAH), scleroderma, Raynaud's phenomenon and other diseases in which the blood vessels are constricted and blood can't flow to the tissues. Highlights Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Iloprost Drugs market is projected to reach US$ 80 million by 2028 from an estimated US$ 88 million in 2022, at a CAGR of -1.6% during 2023 and 2028. North Americ......
  • Global Treprostinil Drugs Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028
    Published: 29-Sep-2022        Price: US 5900 Onwards        Pages: 85
    Treprostinil is a vasodilator that is used for the treatment of pulmonary arterial hypertension. Highlights Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Treprostinil Drugs market is projected to reach US$ 1570.4 million by 2028 from an estimated US$ 1292.5 million in 2022, at a CAGR of 3.3% during 2023 and 2028. North America is the largest consumption place, with a consumption market share nearly 92% in 2018. Following......
  • Global Swine Reproductive and Respiratory Syndrome Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028
    Published: 29-Sep-2022        Price: US 5900 Onwards        Pages: 126
    Swine reproductive and respiratory syndrome is an acute and highly contagious viral infection characterized by reproductive disorder and respiratory symptoms in pig population. Highlights Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Swine Reproductive and Respiratory Syndrome Vaccine market is projected to reach US$ 844.2 million by 2028 from an estimated US$ 471.4 million in 2022, at a CAGR of 10.2% during 2023 and 2028.......
  • Global Bio Implant Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 29-Sep-2022        Price: US 5600 Onwards        Pages: 132
    Report Scope This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers' production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Bio Implant manufacturers, distributors, end users, industry associations, governments' industry bureaus, industry publicat......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs